Hi

Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study

JNJ says data from study 'do not speak to the full nature of immune protection'. The one-shot coron
Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Top
  • Latest
  • Baldy
    ·2021-07-21
    Help like ty
    Reply
    Report